a month ago
IRON
AnalystsBenjamin BurnettBenjamin Burnett's Stock Forecasts
AnalystsBenjamin Burnett
Sectors:
Industries:
Analyst Ranking
Bottom 15%
#3917 out of 4551 analysts
Average Return
-2.66%
Win Rate
33%14 out of 42
Risk vs Reward
Poor
Good
Benjamin Burnett's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gracell Biotechnologies IncGRCL | +271.38% | $2.76 | $10.25 | 2023-10-18 - 2024-02-21 | Strong Buy |
Cti Biopharma CorpCTIC | +134.68% | $2.22 | $5.21 | 2021-05-05 - 2022-05-05 | Strong Buy |
Arcellx IncACLX | +134.31% | $30.11 | $70.55 | 2023-03-13 - 2024-03-13 | Strong Buy |
Iovance Biotherapeutics IncIOVA | +126.19% | $5.27 | $11.92 | 2023-09-14 - 2024-04-16 | Strong Buy |
Iovance Biotherapeutics IncIOVA | +119.32% | $5.44 | $11.92 | 2023-09-12 - 2024-04-16 | Strong Buy |
Benjamin Burnett Analyst Color
Get additional color on Benjamin Burnett's coverage of popular stocks
Benjamin Burnett's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Disc Medicine IncIRON | 5 | Strong Buy | $73.00 | +143.90% | Maintains | 10 days ago |
Atara Biotherapeutics IncATRA | 2 | Hold | $2.30 | +237.24% | Maintains | 17 days ago |
Arcellx IncACLX | 3 | Strong Buy | $82.00 | +48.50% | Reiterates | a month ago |
Kinnate Biopharma IncKNTE | 5 | Hold | $2.59 | -2.26% | Maintains | 2 months ago |
Gracell Biotechnologies IncGRCL | 2 | Hold | $10.25 | 0.00% | Downgrades | 2 months ago |
Mirati Therapeutics IncMRTX | 6 | Hold | $59.00 | +0.51% | Downgrades | 5 months ago |
Cabaletta Bio IncCABA | 1 | Strong Buy | $31.00 | +90.30% | Initiates Coverage On | 6 months ago |
Repare Therapeutics IncRPTX | 4 | Strong Buy | $17.00 | +408.98% | Maintains | 7 months ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $47.00 | +29.66% | Maintains | 7 months ago |
Iovance Biotherapeutics IncIOVA | 9 | Strong Buy | $25.00 | +109.73% | Reiterates | 7 months ago |
Effector Therapeutics IncEFTR | 4 | Strong Buy | $175.00 | +8,693.97% | Upgrades | a year ago |
Cti Biopharma CorpCTIC | 2 | Hold | $9.10 | +0.11% | Downgrades | a year ago |
Crispr Therapeutics AgCRSP | 5 | Hold | $64.00 | +10.42% | Maintains | a year ago |
Allogene Therapeutics IncALLO | 3 | Hold | $7.50 | +114.29% | Maintains | a year ago |
Fate Therapeutics IncFATE | 2 | Hold | $5.00 | -7.06% | Maintains | a year ago |
Ideaya Biosciences IncIDYA | 4 | Strong Buy | $24.00 | -41.71% | Upgrades | a year ago |
Neurogene IncNGNE | 2 | Hold | $4.50 | N/A | Downgrades | a year ago |
Global Blood Therapeutics IncGBT | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Genocea Biosciences IncGNCAQ | 1 | Hold | $0.16 | N/A | Downgrades | 2 years ago |
Precision Biosciences IncDTIL | 2 | Strong Buy | $780.00 | N/A | Maintains | 3 years ago |
Nektar TherapeuticsNKTR | 2 | Strong Buy | $24.00 | N/A | Upgrades | 3 years ago |
Precigen IncPGEN | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | 3 years ago |
Sangamo Therapeutics IncSGMO | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 3 years ago |
Beam Therapeutics IncBEAM | 1 | Hold | $84.00 | N/A | Initiates Coverage On | 3 years ago |
Bluebird Bio IncBLUE | 1 | Strong Buy | $70.00 | N/A | Upgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.